Jones James bought CPIX
December 26, 2025 · Form 4 insider transaction
Jones James bought 8 shares of Cumberland Pharmaceuticals Inc. at $4.21 per share, a transaction worth $33.68. The trade was recorded as l under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 11 days after the transaction.
Direction
Acquired (buy-side)
Shares
8
Price
$4.21
Total value
$33.68
InsiderJones James
Role—
SecurityCommon Stock
Transaction codeL: L
Transaction dateDecember 26, 2025
Filing dateJanuary 6, 2026
Shares owned after45,040
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.